로그인 회원가입
icon_bulk_order대량 주문 조회 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > PLAU

PLAU

요약

Name:Urokinase plasminogen activator
Target Synonym:PLAU,uPA,Plasminogen Activator, Urokinase,Urokinase-Type Plasminogen Activator,Plasminogen Activator, Urinary,BDPLT5,U-PA,ATF,QPD,URK,EC 3.4.21,EC:3.4.21.73,U-Plasminogen Activator,EC 3.4.21.73
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Approved

제품 리스트 비교 또는 구매

제품 상태별:
제품 유형별 :
종별:
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
PLU-H5228 Human Human PLAU / uPA Protein, His Tag (activated by trypsin) (active enzyme)
PLU-H5228-structure
PLU-H5228-sds
PLU-H5229 Human Human PLAU / uPA Protein, His Tag
PLU-H5229-structure
PLU-H5229-sds

일부의 생물활성 데이터

PLU-H5229-MALS-HPLC
Human PLAU, His TagHuman PLAU, His Tag (Cat. No. PLU-H5229) ELISA bioactivity

Immobilized Human PLAU, His Tag (Cat. No. PLU-H5229) at 5 μg/mL (100 μL/well) can bind Biotinylated Human uPAR, His,Avitag with a linear range of 0.3-2 ng/mL (QC tested).

Synonym Name

Urokinase,PLAU,ATF,UPA,URK,u-PA,BDPLT5,QPD

Background

Urokinase - type plasminogen activator is also known as PLAU and UPA, a serine protease with an extremely limited substrate specificity, cleaving the sequence Cys – Pro – Gly - Arg560 - Val561 – Val – Gly – Gly – Cys in plasminogen to form plasmin. uPA is a potent marker of invasion and metastasis in a variety of human cancers associated with breast, stomach, colon, bladder, ovary, brain and endometrium.uPA and its receptor (uPAR) have been implicated in a broad spectrum of pathophysiological processes, including fibrinolysis, proteolysis, inflammation, atherogenesis and plaque destabilization, all of which are involved in the pathogenesis of MI (myocardial infarction).

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Urokinase biosimilar (Sedico) Approved Sedico Angikinase Egypt Pulmonary Embolism; Myocardial Infarction; Thromboembolism Sedico 2014-01-01 Pulmonary Embolism; Myocardial Infarction; Thromboembolism Details
Nasaruplase GE-0943 Approved Mitsubishi Pharma Corp Tomieze, Thrombolyse Japan Myocardial Infarction; Venous Thrombosis Mitsubishi Pharma Corp 1992-01-01 Myocardial Infarction; Venous Thrombosis Details
Urokinase biosimilar (Bharat Serums & Vaccines) U-FRAG Approved Bharat Serums And Vaccines Pulmonary Embolism Details
Tisokinase AK-124 Approved Kowa Co Ltd, Asahi Kasei Corp Plasvata, Hapase Japan Myocardial Infarction; Thrombosis null 1991-01-01 Myocardial Infarction; Thrombosis Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Gallium-68 NOTA AE105 (Curasight) CS-001; 68Ga-NOTA-AE105 Phase 2 Clinical Curasight Head and Neck Neoplasms; Glioblastoma; Neuroendocrine Tumors; Mesothelioma; Urinary Bladder Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Oropharyngeal Neoplasms; Genital Neoplasms, Female; Carcinoma, Non-Small-Cell Lung Details
Urokinase biosimilar (Suzhou Landing Biological Pharmaceutical) Phase 3 Clinical Suzhou RxD Biopharmaceutical Co Ltd ST Elevation Myocardial Infarction Details
WX-UK1 WX-UK1 Wilex Details
Recombinant human annexin 5 protein (Yabao Pharmaceuticals) SY-005 Phase 2 Clinical Lawson Health Research Institute, Yabao Pharmaceutical Group Co Ltd Sepsis Details
Angstrom6 A6 Angstrom Details
tPA/HisproUK (Thrombolytic Science) TS-01 Thrombolytic Science Details
Upamostat Hydrogen Sulphate WX-671; LH-011; RHB-107 Phase 1 Clinical Wilex Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Breast Neoplasms Details

This web search service is supported by Google Inc.

totop